News for Your Practice
News for Your Practice
New group B strep guidelines clarify management of key groups
The CDC’s latest recommendations, endorsed by ACOG, spell out screening and intrapartum prophylaxis among women who experience preterm labor,...
News for Your Practice
Cease the practice of early elective delivery, says March of Dimes
Elective delivery before 39 full weeks of gestation must end if birth outcomes are to improve, organization asserts
News for Your Practice
Quadrivalent HPV vaccine now FDA-approved to prevent anal cancer
Most cases of anal cancer are diagnosed in women. HPV vaccination may prevent cancer or limit the burden of disease, the agency declares
News for Your Practice
Women who have low sexual arousal may respond to simple measures
One third of female subjects in a recent trial who received placebo for low sexual arousal had a meaningful response—suggesting that, in some...
News for Your Practice
Why you should recommend flu vaccine to "every single patient"
Routinely raise the subject, especially with pregnant patients, ACOG says
News for Your Practice
New study reveals a link between estrogen-progestin HRT and advanced breast cancer
Data from the Women’s Health Initiative show that mortality is higher in postmenopausal women who develop breast cancer after taking combined...
News for Your Practice
Twitter 101 for ObGyns: Pearls, pitfalls, and potential
Picture a vast social network through which you speak to its millions of members—including your peers and patients. That kind of access might...
News for Your Practice
14 questions (and answers) about health reform and you
The Patient Protection and Affordable Care Act has ramifications for ObGyns and their patients. ACOG’s director of government affairs answers our...
News for Your Practice
FDA warning: Don’t use unapproved IUDs
Physicians who insert counterfeit IUDs may be putting themselves and their patients at risk, the FDA warns
News for Your Practice
Another reason to postpone delivery until 37 weeks
A study confirms: Late preterm births are associated with an increased risk of respiratory illness
News for Your Practice
Why the FDA asked for more testing on flibanserin for HSDD
But the panel points to “widespread unmet need” for a medical therapy for HSDD in recommending that the drug maker continue to study the agent